Cargando…
Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649345/ http://dx.doi.org/10.1186/2051-1426-3-S2-P349 |
| _version_ | 1782401338029637632 |
|---|---|
| author | Baird, Jason Friedman, David Cottam, Benjamin Crittenden, Marka Gough, Michael |
| author_facet | Baird, Jason Friedman, David Cottam, Benjamin Crittenden, Marka Gough, Michael |
| author_sort | Baird, Jason |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493452015-11-24 Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy Baird, Jason Friedman, David Cottam, Benjamin Crittenden, Marka Gough, Michael J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649345/ http://dx.doi.org/10.1186/2051-1426-3-S2-P349 Text en Copyright © 2015 Baird et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Baird, Jason Friedman, David Cottam, Benjamin Crittenden, Marka Gough, Michael Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy |
| title | Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy |
| title_full | Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy |
| title_fullStr | Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy |
| title_full_unstemmed | Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy |
| title_short | Tumor control by intravenous administration of STING ligand requires combination with precisely timed radiation therapy |
| title_sort | tumor control by intravenous administration of sting ligand requires combination with precisely timed radiation therapy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649345/ http://dx.doi.org/10.1186/2051-1426-3-S2-P349 |
| work_keys_str_mv | AT bairdjason tumorcontrolbyintravenousadministrationofstingligandrequirescombinationwithpreciselytimedradiationtherapy AT friedmandavid tumorcontrolbyintravenousadministrationofstingligandrequirescombinationwithpreciselytimedradiationtherapy AT cottambenjamin tumorcontrolbyintravenousadministrationofstingligandrequirescombinationwithpreciselytimedradiationtherapy AT crittendenmarka tumorcontrolbyintravenousadministrationofstingligandrequirescombinationwithpreciselytimedradiationtherapy AT goughmichael tumorcontrolbyintravenousadministrationofstingligandrequirescombinationwithpreciselytimedradiationtherapy |